期刊文献+

曲古抑霉素A对骨肉瘤细胞增殖和迁移能力的影响及其机制

Effect of trichostatin A on the proliferation and migration of osteosarcoma cell lines and its mechanism
原文传递
导出
摘要 目的探讨曲古抑霉素A(TSA)对骨肉瘤细胞增殖和迁移能力的影响及其可能的作用机制。方法不同浓度的TSA处理骨肉瘤MG-63、U2OS细胞48 h,镜下观察细胞形态的改变,CCK8法检测不同浓度对肿瘤细胞的抑制效果,并计算其半数抑制浓度;TSA处理48 h后,以流式细胞术检测对骨肉瘤细胞周期的影响;Transwell法检测TSA对骨肉瘤细胞迁移能力的影响;Western blot检测TSA对骨肉瘤细胞GSK3β、pGSK3β蛋白的影响。结果 TSA处理后,骨肉瘤细胞细胞质减少,失去细胞连接;不同细胞系对TSA的敏感程度不同,与MG-63细胞相比,U2OS细胞更加敏感。流式细胞技术检测结果显示TSA可以使细胞G2/M期增加,G1期和S期减少,将细胞阻滞于G2/M期(P<0.05)。Transwell结果显示TSA可以明显降低骨肉瘤细胞的迁移能力(P<0.05)。Western blot结果表明,TSA并不改变GSK3β的表达,但可以降低pGSK3β的表达(P<0.05)。结论 TSA可以明显抑制骨肉瘤细胞的增殖以及迁移能力,具有显著的抗肿瘤作用,并且这一作用可能是通过下调pGSK3β蛋白表达发挥作用的。 Objective To investigate the effect of trichostatin A (TSA) on proliferation and migration of osteosarcoma and its possible mechanism. Methods Osteosarcoma MG-63 and U2OS cells were treated in different concentrations of TSA for 48 hours. The morphological changes of osteosarcoma were observed under microscope. Calculate the 50%inhibitory concentration (IC50). After treatment for 48 hours, observe the cell cycle change by flow cytometer;Transwell assay was used to detect the influence of TSA on migration of osteosarcoma;Western blot was used to observe the change of GSK3β, pGSK3β proteins. Results After TSA treatment, cytoplasm was reduced and osteosarcoma lost cell junctions. Different cell lines had different sensitivities to TSA. Compared with the MG-63 cell line, U2OS cell line was more sensitive. Flow cytometry showed that TSA could make G2/M phase increase and G1 phase and S phase decrease, so cells were arrested at G2/M phase. Transwell assay showed TSA could significantly reduce migration of osteosarcoma in vitro. Western blot showed that TSA did not change GSK3βexpression, but it could reduce pGSK3βexpression. Conclusion TSA could inhibit cell proliferation and migration of osteosarcoma. Therefore TSA has significant anti-tumor effect, and this effect may be through down pGSK3βprotein play a role.
出处 《中华临床医师杂志(电子版)》 CAS 2013年第18期149-151,共3页 Chinese Journal of Clinicians(Electronic Edition)
关键词 细胞增殖 细胞运动 曲古抑霉素A GSK313 pGSK313 Cell proliferation Cell movement Trichostatin A GSK3β pGSK3β
  • 相关文献

参考文献14

  • 1Geller DS,Gorlick R. Osteosarcoma:a review of diagnosis,management,and treatment strategies[J].Clin Adv Hematol Oncol,2010.705-718.
  • 2Ferrari S,Palmerini E. Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma[J].Current Opinion in Oncology,2007,(4):341-346.doi:10.1097/CCO.0b013e328122d73f.
  • 3Chao KC,Chang CC,Yen MS. Anti-tumor activity of histone deacetylase inhibitors and the effect on ATP-binding cassette in ovarian carcinoma cells[J].European Journal of Gynaecological Oncology,2010.402-410.
  • 4Zhu S,Li Y,Zhao L. TSA-induced JMJD2B downregulation is associated with cyclin B1-dependent survivin degradation and apoptosis in LNCap cells[J].Journal of Cellular Biochemistry,2012.2375-2382.
  • 5Li S,Wang B,Xu Y. Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis[J].Molecular Cancer Therapeutics,2011.18.
  • 6程冬冬,刘蕾,张智长,杨庆诚.组蛋白去乙酰化酶抑制剂抗骨肉瘤活性的体内实验研究[J].实验动物与比较医学,2013,33(1):47-51. 被引量:1
  • 7Williams RJ. Trichostatin A,an inhibitor of histone deacetylase,inhibits hypoxia-induced angiogenesis[J].Expert Opinion on Investigational Drugs,2001.1571-1573.
  • 8Kim MS,Kwon HJ,Lee YM. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes[J].Nature Medicine,2001.437-443.
  • 9Seo JS,Cho NY,Kim HR. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor,Trichostatin A[J].Oncology Reports,2008.93-98.
  • 10Hsu YF,Sheu JR,Hsiao G. p53 in trichostatin A induced C6 glioma cell death[J].Biochimica Et Biophysica Acta,2011.504-513.

二级参考文献8

  • 1于哲,范清宇,张婷.大鼠骨肉瘤模型的建立[J].动物医学进展,2005,26(2):58-60. 被引量:9
  • 2李艳,向理科,罗娟,王智彪.原位异种移植性骨肉瘤的动物模型及生物学特性的初步观察[J].重庆医科大学学报,2006,31(2):137-140. 被引量:5
  • 3Ek ET, Dass CR, Choong PF. Commonly used mouse models of osteosarcoma [J]. Crit Rev Oncol Hematol, 2006, 60(1): 1-8.
  • 4Wagner JM, Hackanson B, Ltibbert M, et al. Histone deacetylase(HDAC) inhibitors in recent clinical trials for cancer therapy [J]. Clin Epigenetics, 2010, 1 (3-4): 117-136.
  • 5Ory B, Heymann MF, Kamijo A, et al. Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing mice [J]. Cancer, 2005, 104(11):2522- 2529.
  • 6Ellis L, Pili R. Histone deacetylase inhibitors: advancing therapeutic strategies in hematological and solid malignancies [J]. Pharmaceuticals (Basel), 2010, 3(8):2411-2469.
  • 7丁凡,邵增务.组蛋白去乙酰化酶抑制剂对人骨肉痛细胞抑制增殖和诱导分化的研究[J].中国矫形外科杂忠,2010,18(131:1111-1114.
  • 8杨庆诚,曾炳芳,张立智,张智长.组蛋白去乙酰化酶抑制剂对骨肉瘤MNNG/HOS细胞凋亡的影响[J].肿瘤,2010,30(12):1004-1008. 被引量:4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部